BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stanford GE, Dave K, Simmonds NJ. Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape. Chest 2021;159:93-102. [PMID: 32966813 DOI: 10.1016/j.chest.2020.09.084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabnis A, Hagart KL, Klöckner A, Becce M, Evans LE, Furniss RCD, Mavridou DA, Murphy R, Stevens MM, Davies JC, Larrouy-Maumus GJ, Clarke TB, Edwards AM. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 2021;10:e65836. [PMID: 33821795 DOI: 10.7554/eLife.65836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Taccetti G, Francalanci M, Pizzamiglio G, Messore B, Carnovale V, Cimino G, Cipolli M. Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives. Antibiotics (Basel) 2021;10:338. [PMID: 33810116 DOI: 10.3390/antibiotics10030338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Simmonds NJ. Introducing the Adult Cystic Fibrosis Series: An Exciting Time of Change, But New Challenges Lie Ahead. Chest 2021;159:3-4. [PMID: 33422202 DOI: 10.1016/j.chest.2020.10.020] [Reference Citation Analysis]
4 Scialo F, Amato F, Cernera G, Gelzo M, Zarrilli F, Comegna M, Pastore L, Bianco A, Castaldo G. Lung Microbiome in Cystic Fibrosis. Life (Basel) 2021;11:94. [PMID: 33513903 DOI: 10.3390/life11020094] [Reference Citation Analysis]
5 Bingle CD, Bingle L. SPLUNC1 comes of age? Predicting acute exacerbations in cystic fibrosis. Eur Respir J 2021;58:2101569. [PMID: 34764214 DOI: 10.1183/13993003.01569-2021] [Reference Citation Analysis]
6 Alhajj N, O'Reilly NJ, Cathcart H. Development and Characterization of a Spray-Dried Inhalable Ciprofloxacin-Quercetin Co-Amorphous System. Int J Pharm 2022;:121657. [PMID: 35288220 DOI: 10.1016/j.ijpharm.2022.121657] [Reference Citation Analysis]
7 Nordengrün M, Abdurrahman G, Treffon J, Wächter H, Kahl BC, Bröker BM. Allergic Reactions to Serine Protease-Like Proteins of Staphylococcus aureus. Front Immunol 2021;12:651060. [PMID: 33833764 DOI: 10.3389/fimmu.2021.651060] [Reference Citation Analysis]
8 Girón Moreno RM, García-Clemente M, Diab-Cáceres L, Martínez-Vergara A, Martínez-García MÁ, Gómez-Punter RM. Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review. Antibiotics (Basel) 2021;10:486. [PMID: 33922413 DOI: 10.3390/antibiotics10050486] [Reference Citation Analysis]
9 Mingora CM, Flume PA. Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future. Chest 2021:S0012-3692(21)01127-2. [PMID: 34147501 DOI: 10.1016/j.chest.2021.06.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Chance DL, Mawhinney TP. Observations of, and Insights into, Cystic Fibrosis Mucus Heterogeneity in the Pre-Modulator Era: Sputum Characteristics, DNA and Glycoprotein Content, and Solubilization Time. JoR 2020;1:8-29. [DOI: 10.3390/jor1010002] [Reference Citation Analysis]